Risk of atrial fibrillation with ibandronate: results from the pivotal clinical trials.
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Parent Publication: Mayo Clinic Proceedings